• Blueberry Therapeutics raises £10M funding to develop nanomedicines biospectrumasia
    August 20, 2018
    Blueberry Therapeutics will use the net proceeds of the Series B Fundraising to fund its development programme for BB2603 for the treatment of onychomycosis and tinea pedis, as well as progressing its earlier stage acne, topical analgesia and atopic derma
PharmaSources Customer Service